PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

Disease, Chronic Clinical Trial

Official title:

PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03617380
• Other study ID #: 171847
• Status: Withdrawn
• Phase: N/A
• Start date: October 1, 2018
• Est. completion date: February 10, 2020

Study information

• Verified date: February 2020
• Source: University of California, San Diego
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Many hospitals and medical groups have developed transitions of care (TOC) programs or procedures in an attempt to reduce hospital readmission and reutilization rates of patients discharged from the hospital. As healthcare's most accessible practitioners, Community Pharmacists have a unique opportunity to assist with reducing unnecessary hospital re-utilization (re-admissions and emergency department visits) after hospital discharge. The purpose of this study is to conduct and evaluate the implementation of a Community Pharmacy-based Transitions of Care (TOC) Program for high-risk post-discharge patients of PIH Health Hospital-Whittier (PIH). The primary objective will be to compare the proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge between patients randomly assigned to the PHARMD-TOC group vs. the historic rate at PIH. Secondary analyses will examine differences between groups and describe implementation details of the PHARMD-TOC model of patient care.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: February 10, 2020
• Est. primary completion date: February 10, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• - Admission LACE Score: in moderate range (5 to 9) And

• Taking high risk medication(s): anticoagulants, insulin, oral antiplatelet agents, oral hypoglycemic agents, opioid analgesics, digoxin Or Taking at least 5 medications AND have one of following: CHF, COPD, Asthma, Pneumonia, Diabetes, ESRD, Schizophrenia, Bi-Polar, Dizziness, History of Falls

And

• Medical or Surgical Unit patients

• Age > 18 years

• Being discharged to home (with or without Home Health services)

• English and/or Spanish speaking

• Will have access to a telephone post-discharge

• Ability to give consent

• Patient admitted to hospital through the emergency department, as a direct admission or as a transfer, or as an elective surgery patient

Exclusion Criteria:

• - Patients with observation status

• Caremore Health Plan patients (Caremore has a separate post-discharge program)

• Patients discharged and followed up by the PIH Coumadin Clinic

• Patients discharged to Residential MD House Calls program

• Patients discharged to Skilled Nursing Facility

• Anyone with planned readmissions

• Obstetrics patients

• Hospice patients

• Oncology patients

• Anyone who does not meet provisions of protocol

• Anyone unwilling or unable to give consent for study procedures and data access

Related Conditions & MeSH terms

• Chronic Disease
• Disease, Chronic

Intervention

Other:
• Usual Care
patients participating Usual Care discharge services
• PharmD TOC
patients participating in a community pharmacy-based Transitions of Care Program (PHARMD-TOC)

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Diego

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion Patients with Hospital Reutilization	proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge	30 days post hospital discharge